What women with ovarian cancer think and know about genetic testing

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 132-136

  Lacour, Robin A ^a   Daniels, Molly S ^a   Westin, Shannon N ^a   Meyer, Larissa A ^a   Burke, Catherine C ^a   Burns, Kimberly A ^a   Kurian, Shiney ^a   Webb, Nicki F ^a   Pustilnik, Terri B ^b   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Gynecologic Oncology of Houston   (United States)

Author keywords

Acceptance; Genetic testing; Knowledge; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CANCER GENETICS; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES;

EID: 52049087559     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.016     Document Type: Article

References (16)

1. Ozols R.F., Rubin S.C., Thomas G.M., and Robboy S.J. Epithelial ovarian cancer. In: Hoskins W.J., et al. (Ed). Principles and practice of gynecologic oncology. 4th ed (2005), Lippincott Williams & Wilkins, Philadelphia 895-987
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Risch H.A., McLaughlin J.R., Cole D.E.C., et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68 (2001) 700-710
4. Pal T., Permuth-Wey J., Betts J.A., et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104 (2005) 2807-2816
5. Lancaster J.M., Powell C.B., Kauff N.D., et al. Gynecol Oncol 107 (2007) 159-162
6. McCabe N., Turner N.C., Lord C.J., et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 66 (2006) 8109-8115
7. Farmer H., McCabe N., Lord C.J., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434 (2005) 917-921
8. DeSoto J.A., and Deng C. PARP-1 inhibitors: are they the long-sought genetically specific drug for BRCA 1/2-associated breast cancers?. Int J Med Sci 3 (2006) 117-123
9. Kelly K., Leventhal H., Andrykowski M., et al. The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. J Genet Couns 13 (2004) 237-257
10. Kieran S., Loescher L.J., and Lim K.H. The role of financial factors in acceptance of clinical BRCA genetic testing. Genetic Testing 11 (2007) 101-110
11. Frank T.S., Deffenbaugh A.M., Reid J.E., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20 (2002) 1480-1490
12. Thompson H.S., Valdimarsdottir H.B., Duteau-Buck C., et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African American women. Cancer Epidemiol Biomarkers Prev 11 (2002) 1579-1585
13. Susswein L.R., Skrzynia C., Lange L.A., Booker J.K., Graham III M.L., and Evans J.P. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol 26 (2008) 32-36
14. Schlich-Bakker K.J., Ten Krode H.F.J., Warlam-Rodenhuis C.C., Van den Bout J., and Ausems M.G.E.M. Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer. Genet Med 9 (2007) 766-777
15. Philips Z., Whynes D.K., and Avis M. Testing the construct validity of willingness to pay valuations using objective information about risk and health benefit. Health Econ 15 (2006) 195-204
16. Bosompra K., Ashikaga T., Flynn B.S., Worden J.K., and Solomon L.J. Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model. Health Educ Res 16 (2001) 157-172